Are you from this Company?
QIAGEN NV
Hilden, Germany
1984
$1BN to $5BN
Enterprise
97 Likes
73 Buyers Negotiating
Strengths
  • +13
    GLP/Manufacturing excellence practices
  • +8
    Pharmaceuticals and Biotechnology
  • +14
    IVTT Assays
  • +8
    ADME
  • +5
    Highthroughput screening
  • +9
    Skin irritation
  • +5
    Breadth and Depth of Product Offerings
  • +8
    Product Differentiation and Impact on Customer Value
  • +6
    Product Quality and Reliability
  • +7
    Focus on Product Innovation
  • +11
    Cytotoxicity
  • +14
    Cell culture technology
  • +9
    Cosmetics
  • +5
    IVTT Services
  • +10
    Genotoxicity
  • +6
    Cellular imaging
  • +10
    Food
  • +6
    IVTT Reagents
  • +11
    Chemical
  • +7
    Toxicogenomics
Cautions
  • -12
    Other products

QIAGEN NV Reviews

user-icon

Buyer, SME Company

5
Jan 26, 2023
I recently purchased QIAGEN NVs in vitro toxicology testing and was very pleased with the results. The technical features of the product are outstanding and allowed me to assess several different types of toxicities quickly and easily. The cost is also very reasonable, especially when compared with the high quality results of the tests. Additionally, the support provided by the company was quite helpful and the product seemed to be well suited for futuristic applications of toxicology testing. Overall, I was very pleased with the product and believe it to be a great investment. I have also found that the product provides an excellent return on investment, given its cost and the quality of the results. In addition, the financial stability of the company gave me comfort in my purchase decision, as did the maturity of their business model. Furthermore, their supply chain operations seemed to be quite organized and efficient. The production capacity is quite impressive, as is their commitment to research and innovation. Finally, the product has always been available and turnaround time is fairly reasonable. The product also has the ability to be customized to meet the specific needs of your laboratory. Overall, I am extremely pleased with my purchase of QIAGEN NVs in vitro toxicology testing and highly recommend it to anyone looking for a reliable and cost effective option. The product has proven to be well worth the cost and has exceeded my expectations. I would rate it a 9 out of 10.
Read less Read more
Useful (0) Not useful (0)
user-icon

Buyer, Europe SME Company

5
Nov 20, 2022
I recently purchased QIAGEN NVs in vitro toxicology testing and was very pleased with the results. The technical features of the product are outstanding and allowed me to assess several different types of toxicities quickly and easily. The cost is also very reasonable, especially when compared with the high quality results of the tests. Additionally, the support provided by the company was quite helpful and the product seemed to be well suited for futuristic applications of toxicology testing. Overall, I was very pleased with the product and believe it to be a great investment. I have also found that the product provides an excellent return on investment, given its cost and the quality of the results. In addition, the financial stability of the company gave me comfort in my purchase decision, as did the maturity of their business model. Furthermore, their supply chain operations seemed to be quite organized and efficient. The production capacity is quite impressive, as is their commitment to research and innovation. Finally, the product has always been available and turnaround time is fairly reasonable. The product also has the ability to be customized to meet the specific needs of your laboratory. Overall, I am extremely pleased with my purchase of QIAGEN NVs in vitro toxicology testing and highly recommend it to anyone looking for a reliable and cost effective option. The product has proven to be well worth the cost and has exceeded my expectations. I would rate it a 9 out of 10.
Read less Read more
Useful (0) Not useful (0)
I agree to 360Quadrants Terms of use and privacy policy
Success
info
Error
Company Size :
  Enterprise
  SME
  Startup